Sylvia Marie Kiertscher

Title: Sylvia Marie Kiertscher: Innovator in Immunotherapy

Introduction

Sylvia Marie Kiertscher is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of immunotherapy, particularly in enhancing anti-tumor responses in human patients. Her innovative approaches have the potential to improve cancer treatment outcomes.

Latest Patents

Kiertscher holds a patent titled "Methods for enhancing antigen-presenting cells and anti-tumor responses in a human patient." This invention provides methods for enhancing the development of antigen-presenting cells (APC) from precursor cells by administering a combination of GM-CSF and IL-4. The precursor cells include those contained in peripheral blood, CD cells, and precursors in bone marrow. The administration of GM-CSF and IL-4 can be utilized as a form of cytokine immunotherapy. One embodiment of this invention involves systemic administration of GM-CSF and IL-4, allowing APC to directly access tumor antigens as they exist in vivo within the patient. Another embodiment describes the co-administration of a tumor-associated or tumor-specific antigen, along with GM-CSF and IL-4, to induce antigen-specific immunity mediated by APC. Additionally, systemic administration of GM-CSF and IL-4 aims to achieve reduced tumor burden.

Career Highlights

Kiertscher is affiliated with the University of California, where she continues her research and development in immunotherapy. Her work has garnered attention for its innovative approach to cancer treatment.

Collaborations

Some of her notable coworkers include Michael Derek Roth and Robert Alan Figlin, who have contributed to her research endeavors.

Conclusion

Sylvia Marie Kiertscher's contributions to immunotherapy through her patent and research at the University of California highlight her role as an influential inventor in the medical field. Her work continues to pave the way for advancements in cancer treatment.